Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1900
-0.0050 (-2.56%)
Aug 26, 2026, 4:10 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 24.41 million as of August 26, 2026. Its market cap has decreased by -72.06% in one year.
Market Cap
24.41M
Enterprise Value
19.37M
Revenue
5.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
ChartMarket Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 24.41M, an increase of 28.29%. That is a compound annual growth rate of 4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 24.41M | -35.59% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 44.96M |
| Nexsen | 44.04M |
| Imugene | 35.75M |
| Noxopharm | 29.19M |
| Proteomics International Laboratories | 27.26M |
| NeuroScientific Biopharmaceuticals | 25.33M |
| EZZ Life Science Holdings | 24.48M |
| Algorae Pharmaceuticals | 22.28M |